Kulasegaran, Tivya http://orcid.org/0009-0002-7873-9350
Oliveira, Niara http://orcid.org/0000-0001-7103-2200
Funding for this research was provided by:
The University of Queensland
Article History
Accepted: 6 May 2024
First Online: 24 June 2024
Compliance with Ethical Standards
:
: Tivya Kulasegaran is a receipt of the Breast Cancer Clinical Fellowship for 2024.Niara Oliveria has received consulting fees and a honoraria speaker for Astellas, Astrazeneca, Bayer, BMS, Eisai, Ipsen, Janseen, Merck, MSD.
: This article does not contain any studies with human or animal subjects performed by any of the authors.